New products

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions.Thymosin Beta-4 Fragment is a short peptide derived from the active region of Thymosin Beta-4, commonly employed in preclinical research to investigate actin-regulated cell migration, angiogenesis, inflammatory modulation, and tissue remodeling mechanisms. In experimental models, it has been studied for its involvement in wound-related cellular dynamics, oxidative stress responses, and regeneration-associated signaling pathways.

Made to Order Compound ✦ Price available upon request. For inquiries: contactus LZ1 is characterized as a 15-residue cationic antimicrobial peptide with: - Strong activity against Gram-positive skin pathogens and certain antibiotic-resistant strains - Negligible hemolytic activity and low cytotoxicity toward keratinocytes - Observed anti-inflammatory effects through modulation of TNF-α and IL-1β pathways - Documented antimalarial activity associated with inhibition of parasite energy metabolism These properties make LZ1 a relevant compound for experimental research in antimicrobial mechanisms, inflammatory signaling, and skin biology.

SLU-PP-332 is a synthetic small-molecule research compound best known as a pan-agonist of ERRα, ERRβ, and ERRγ, a family of nuclear receptors involved in mitochondrial function, oxidative metabolism, and cellular energy regulation. Its main interest lies in its ability to shift tissues toward a more oxidative metabolic state. Rather than acting like a stimulant, it appears to influence upstream transcriptional programs that regulate how cells produce and use energy. This includes effects on mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and overall fuel preference. In preclinical studies, SLU-PP-332 has been associated with increased mitochondrial respiration, enhanced oxidative muscle remodeling, greater reliance on fat oxidation, higher energy expenditure, and improved endurance-related parameters in animal models. It has also shown activity in experimental settings involving metabolic dysfunction, liver fat accumulation, cardiac energy impairment, and age-related mitochondrial decline. Overall, SLU-PP-332 is best described as a preclinical metabolic reprogramming compound with exercise-mimetic and oxidative metabolic activity. It is relevant for research into mitochondrial biology, fuel utilization, and ERR-driven transcriptional regulation.

Summary Bonomarlot, also known as Myelopeptide-2 (MP-2), is a synthetic hexapeptide derived from bone marrow peptides and studied for its immunomodulatory properties in experimental settings. It has demonstrated the ability to restore T-lymphocyte proliferation and normalize key surface markers such as CD3 and CD4 under conditions of immune suppression induced by tumor-derived factors. These effects suggest a role in supporting cellular signaling pathways involved in T-cell activation and functional recovery. Due to its small size and hydrophobic composition, MP-2 may interact efficiently with cellular membranes and protein interfaces, contributing to its biological activity. Current data are limited to preclinical research models, where MP-2 is used as a tool to investigate immune regulation, cellular recovery mechanisms, and tumor-associated immunosuppression.

PNC-28 is a synthetic peptide derived from the p53 protein, specifically from its MDM2-binding domain, and engineered with a penetratin sequence to enable efficient cellular uptake. It is studied for its ability to interact with dysregulated cellular pathways commonly found in transformed cells, particularly involving the MDM2 regulatory system. In experimental models, PNC-28 has been associated with the induction of non-apoptotic cell death mechanisms, characterized by loss of membrane integrity rather than classical programmed cell death. This feature makes it of particular interest in research settings where resistance to apoptosis is observed. Due to its unique mechanism and intracellular activity, PNC-28 is primarily used as a research tool in studies related to tumor biology, cellular stress responses, and alternative cell death pathways.

QK is a synthetic peptide designed to mimic the activity of Vascular Endothelial Growth Factor (VEGF), one of the primary regulators of angiogenesis (the formation of new blood vessels). Unlike full-length VEGF, QK is a smaller and more stable molecule that retains the ability to bind endothelial receptors (particularly VEGFR-1), activating key biological pathways involved in vascular growth. Its primary effect is the stimulation of angiogenesis, through: endothelial cell proliferation and migration formation of new capillary structures improvement of microcirculation These properties make QK highly relevant in research related to: tissue regeneration wound healing ischemic conditions (reduced blood flow) endothelial function and vascular health In summary, QK is a targeted angiogenic mimetic, useful for studying controlled vascular growth in experimental settings, offering improved stability and control compared to natural VEGF.

Glyx-13 has been investigated in preclinical, experimental, and clinical research for its role in NMDA receptor modulation, synaptic plasticity, cognitive processing, and rapid antidepressant-associated neuroadaptive signaling. In particular, research has explored its relevance in: Rapid antidepressant response and reduction of depressive symptoms Treatment-resistant depression research contexts Synaptic plasticity and long-term potentiation (LTP) NMDA receptor modulation and glutamatergic signaling mTORC1-associated synaptic remodeling Dendritic spine formation and synaptic protein expression Cognitive function, attention, and memory-related processes Prefrontal cortical signaling and adaptive neuronal responsiveness Stress-related neural dysfunction Neurobiological mechanisms distinct from ketamine, including the absence of psychotomimetic and dissociative effects in research settings FRESHLY PREPARED SOLUTION 

NEUROTROPHIC ACTIVATION / SYNAPTIC PLASTICITY / NEURAL REPAIR Neuro Regeneration 2 is a dual-phase peptide formulation developed to support research into synaptic plasticity, hippocampal neurogenesis, neuronal repair, and adaptive neurochemical regulation under conditions of neural stress. The formulation is structured in two complementary vials: Vial A focuses on neurotrophic signaling, activity-dependent plasticity, memory-related circuitry, and amyloid-associated synaptic resilience through FGL, Colivelin, P-21, and cAC-253; Vial B is oriented toward structural neural repair, oxidative and apoptotic stress adaptation, circadian support, and neurotransmitter-related regulation through Cortagen, Pinealon, and MIF-1. Together, the system is designed to investigate coordinated mechanisms involved in neuronal differentiation, synaptic maintenance, functional recovery, and long-term neural resilience.FRESHLY PREPARED SOLUTION

TAT-CBD3 is a cell-penetrating peptide designed to modulate neuropathic pain by selectively disrupting the interaction between CRMP-2 and CaV2.2 voltage-gated calcium channels. By reducing calcium influx and excitatory neurotransmitter release, it decreases nociceptor hyperexcitability and abnormal pain signaling. Unlike conventional analgesics, TAT-CBD3 targets upstream molecular mechanisms involved in pain transmission, offering a more selective neuromodulatory approach. Preclinical studies have demonstrated its ability to reduce key features of neuropathic pain, including allodynia, hyperalgesia, and hypersensitivity.